Newbridge Financial Services Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17 | Hold |
2
| – | – | ﹤0.01% | 1301 |
|
|
2025
Q1 | $16 | Sell |
2
-4,600
| -100% | -$36.8K | ﹤0.01% | 1034 |
|
|
2024
Q4 | $41.8K | Sell |
4,602
-3,088
| -40% | -$28.1K | 0.01% | 446 |
|
|
2024
Q3 | $70.6K | Buy |
7,690
+7,290
| +1,823% | +$66.9K | 0.02% | 227 |
|
|
2024
Q2 | $3.91K | Sell |
400
-11,000
| -96% | -$108K | ﹤0.01% | 884 |
|
|
2024
Q1 | $172K | Buy |
11,400
+10,889
| +2,131% | +$164K | 0.08% | 212 |
|
|
2023
Q4 | $11K | Sell |
511
-1,444
| -74% | -$31.1K | 0.01% | 715 |
|
|
2023
Q3 | $36.3K | Buy |
1,955
+100
| +5% | +$1.86K | 0.02% | 496 |
|
|
2023
Q2 | $47K | Sell |
1,855
-1,078
| -37% | -$27.3K | 0.02% | 473 |
|
|
2023
Q1 | $76K | Sell |
2,933
-359
| -11% | -$9.3K | 0.04% | 370 |
|
|
2022
Q4 | $77.9K | Buy |
3,292
+335
| +11% | +$7.92K | 0.04% | 356 |
|
|
2022
Q3 | $75K | Sell |
2,957
-66
| -2% | -$1.67K | 0.04% | 352 |
|
|
2022
Q2 | $100K | Buy |
3,023
+98
| +3% | +$3.24K | 0.06% | 267 |
|
|
2022
Q1 | $211K | Buy |
2,925
+480
| +20% | +$34.6K | 0.1% | 193 |
|
|
2021
Q4 | $224K | Buy |
2,445
+264
| +12% | +$24.2K | 0.11% | 190 |
|
|
2021
Q3 | $277K | Buy |
2,181
+582
| +36% | +$73.9K | 0.17% | 128 |
|
|
2021
Q2 | $266K | Buy |
1,599
+524
| +49% | +$87.2K | 0.16% | 137 |
|
|
2021
Q1 | $195K | Sell |
1,075
-41
| -4% | -$7.44K | 0.14% | 161 |
|
|
2020
Q4 | $223K | Sell |
1,116
-742
| -40% | -$148K | 0.18% | 124 |
|
|
2020
Q3 | $407K | Buy |
+1,858
| New | +$407K | 0.4% | 57 |
|